Population-based reference values for IGF-I and IGF-binding protein-1: Relations with metabolic and anthropometric variables

European Journal of Endocrinology

Volumn 136, Issue 2, 1997, Pages 165-172

  Nyström, Fredrik H ^a   Öhman, Peter K ^a   Ekman, Bertil Å ^a   Österlund, Maria K ^a   Karlberg, Bengt E ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; AGED; AGING; ANTHROPOMETRIC PARAMETERS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031059034     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360165     Document Type: Article

References (35)

1. Brismar K, Fernqvist-Forbes E, Wahren J & Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism 1994 79 872-878.
2. Corpas E, Harman SM & Blackman MR. Human growth hormone and human aging. Endocrine Reviews 1993 14 20-38.
3. Daughaday W, Philips L & Mueller M. The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 1976 98 1214-1219.
4. Bornfeldt KE, Arnqvist HJ, Enberg B, Mathews LS & Norstedt G. Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. Journal of Endocrinology 1989 122 651-656.
5. Binoux M, Hossenlopp P, Lassarre C & Seurin D. Somatomedin production by rat liver in organ culture. Acta Endocrinologica 1980 93 73-82.
6. Ho K, Evans W, Blizzard R, Veldhuis J, Merriam G, Somojlik E et al. Effects of sex and age on 24-hour profile of growth hormone secretion in men: importance of endogenous estradiol concentrations. Journal of Clinical Endocrinology and Metabolism 1987 64 51-58.
7. Blum WF, Albertsson-Wikland K, Rosberg S & Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 1993 76 1610-1616.
8. Hall K, Brismar K, Grissom F, Lindgren B & Po'voa G. IGFBP-1. Production and control mechanisms. Acta Endocrinologica 1991 124 (Suppl 2) 48-54.
9. Lewitt M, Denyer G, Cooney G & Baxter R. Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 1991 129 2254-2256.
10. Frystyk J, Skjærbæk C, Dinesen B & Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters 1994 348 185-191.
11. Plymate SR, Matej LA, Jones RE & Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. Journal of Clinical Endocrinology and Metabolism 1988 67 460-464.
12. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rose'n T, Lindstedt G, Lundberg P-A et al. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology 1994 41 351-357.
13. Fyhrquist F, Soveri P, Puutula L & Stenman U. Radioimmunoassay of plasma renin activity. Clinical Chemistry 1976 22 250-256.
14. Kappelgaard A, Damkjaer-Nielsen M & Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clinica Chimica Acta 1976 67 299-306.
15. Wathen LK, Nuorala KW & Wathen MW. Validation of an immunoradiometric assay to measure plasma levels of active renin. Journal of Clinical Laboratory Analysis 1991 5 284-292.
16. Buttery JE & Stuart S. Assessment and optimization of kinetic methods for angiotensin-converting enzyme in plasma. Clinical Chemistry 1993 39 312-316.
17. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
18. Lindström T, Arnqvist H, Ludvigsson J & von Schenck H. C-peptide profiles in patients with non-insulin-dependent diabetes mellitus before and during insulin treatment. Acta Endocrinologica 1992 126 477-483.
19. Soini E & Kojola H. Time-resolved fluorometer for lanthanide chelates - a new generation of nonisotopic immunoassays. Clinical Chemistry 1983 29 65-68.
20. Fernlund P, Gershagen S, Larsson I & Rannevik G. Radioimmunoassay of human sex hormone binding globulin: improved radioiodination procedure. Scandinavian Journal of Clinical Laboratory Investigation 1985 45 461-469.
21. Rudman D, Vintner M, Rogers C, Lubin M, Fleming G & Raymond P. Impaired growth hormone secretion in the adult population. Relation to age and adiposity. Journal of Clinical Investigation 1981 67 1361-1369.
22. Clemmons D & Van Wyk J. Factors controlling blood concentrations of somatomedin C. Journal of Clinical Endocrinology and Metabolism 1984 13 113-143.
23. Anttila R, Koistinen R, Seppala M, Koistinen H & Siimes MA. Insulin-like growth factor-I and insulin-like growth factor binding protein 3 as determinants of blood hemoglobin concentration in healthy subjects. Pediatric Research 1994 36 745-748.
24. + transport. American Journal of Physiology 1988 255 C413-C417.
25. Di'ez J, Laviades C, Marti'nez E, Gil M, Monreal I, Ferna'ndez J et al. Insulin-like growth factor binding proteins in arterial hypertension: relationship to left ventricular hypertrophy. Journal of Hypertension 1995 13 349-355.
26. Arnqvist HJ, Bornfeldt K, Chen Y & Lindström T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 1995 44 (Suppl 4) 58-66.
27. Bonithon-Kopp C, Ducimetiere P, Touboul PJ, Feve JM, Billaud E, Courbon D et al. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 1994 89 952-954.
28. Rutanen E-M, Bohn H & Seppelä M. Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. American Journal of Obstetrics and Gynecology 1982 144 460-463.
29. Yeoh S & Baxter R. Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinologica 1988 119 465-473.
30. Pekonen FE-MR, Kurunmäki H & Hovatta O. Ovulation induction increases serum levels of insulin-like growth factor binding protein 1. International Journal of Fertility 1992 37 188-191.
31. Lønning P, Helle S-I, Johannessen D, Adlercreutz H, Lien E, Tally M et al. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. Clinical Endocrinology 1995 42 23-30.
32. Rosner W. The function of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocrine Reviews 1990 11 80-91.
33. Rutanen E-M, Kärkkäinen T, Stenman U-H & Yki-Järvinen H. Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. Journal of Clinical Endocrinology and Metabolism 1993 77 1152-1155.
34. Hilding A, Brismar K, Degerblad M, Thore'n M & Hall K. Altered relation between circulating levels of insulin-like growth factor binding protein-1 and insulin in growth hormone-deficient patients and insulin dependent diabetic patients compared with that in healthy subjects. Journal of Clinical Endocrinology and Metabolism 1995 80 2646-2652.
35. Holly J, Cotterill A, Jemmott R, Shears D, Al-Othman S, Chard T et al. Inter-relations between growth hormone, insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone binding globulin in acromegaly. Clinical Endocrinology 1991 34 275-280.